erlotinib hydrochloride has been researched along with Acquired Nephrogenic Diabetes Insipidus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klein, JD; Sands, JM | 1 |
1 review(s) available for erlotinib hydrochloride and Acquired Nephrogenic Diabetes Insipidus
| Article | Year |
|---|---|
Physiological insights into novel therapies for nephrogenic diabetes insipidus.
Topics: Adenylate Kinase; Animals; Aquaporin 2; Diabetes Insipidus, Nephrogenic; Erlotinib Hydrochloride; Humans; Metformin; Mutation; Phosphorylation; Receptors, Vasopressin; Sildenafil Citrate; Simvastatin | 2016 |